Last quarter (Q4 2022), Fisher & Paykel Healthcare Corporation Limited's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Fisher & Paykel Healthcare Corporation Limited's net income was $―. See Fisher & Paykel Healthcare Corporation Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 22	Mar 21	Mar 20	Mar 19	Mar 16
Total Revenue	-	$ 1.64B	$ 1.95B	$ 1.27B	$ 1.07B	$ 818.49M
Cost of Revenue	-	$ 629.00M	$ 725.60M	$ 427.90M	$ 354.60M	$ 293.84M
Gross Profit	-	$ 1.01B	$ 1.22B	$ 845.50M	$ 717.50M	$ 524.65M
Operating Expense	-	$ 643.10M	$ 618.30M	$ 517.50M	$ 428.20M	$ 315.57M
Operating Income	-	$ 370.30M	$ 604.30M	$ 328.00M	$ 289.30M	$ 209.09M
Net Non Operating Interest Income Expense	-	$ -2.30M	$ -3.50M	$ -1.70M	$ -1.40M	$ -10.25M
Other Income Expense	-	$ 40.20M	$ 32.40M	$ -16.80M	$ 3.30M	$ 2.00M
Pretax Income	-	$ 504.20M	$ 718.20M	$ 370.50M	$ 291.20M	$ 200.83M
Tax Provision	-	$ 127.30M	$ 194.00M	$ 83.20M	$ 82.00M	$ 57.41M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	$ 376.90M	$ 524.20M	$ 287.30M	$ 209.20M	$ 143.43M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	-	-	-	-	-	-
Net Income From Continuing And Discontinued Operation	-	$ 376.90M	$ 524.20M	$ 287.30M	$ 209.20M	$ 143.43M
Normalized Income	-	$ 376.90M	$ 524.20M	$ 287.30M	$ 209.20M	$ 143.43M
Interest Expense	-	$ 4.90M	$ 5.00M	$ 3.90M	$ 4.70M	$ 10.35M
EBIT	-	$ 509.10M	$ 723.20M	$ 374.40M	$ 295.90M	$ 211.18M
EBITDA	-	$ 605.10M	$ 808.20M	$ 435.40M	$ 295.90M	$ 211.18M

Currency in NZD

Fisher & Paykel Healthcare Corporation Limited Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing